Tuesday, February 03, 2026 | 12:43 PM ISTहिंदी में पढें
Shukra Pharmaceuticals Ltd
Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report.
02:58 PM, 30th Jan 2026
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Unaudited financial result for the Third Quarter ended on 31 December 2025 along with the Auditors Limited Review Report.